I 

110TH CONGRESS 

1ST SESSION H. R. 1560 

To amend the Public Health Service Act to fund breakthroughs in Alzheimer’s 

disease research while providing more help to caregivers and increasing 

public education about prevention. 

IN THE HOUSE OF REPRESENTATIVES 

MARCH 19, 2007 

Mr. MARKEY (for himself and Mr. SMITH of New Jersey) introduced the 

following bill; which was referred to the Committee on Energy and Commerce 

A BILL 

To amend the Public Health Service Act to fund breakthroughs in Alzheimer’s disease research while providing 

more help to caregivers and increasing public education 

about prevention. 

1 Be it enacted by the Senate and House of Representa2 tives of the United States of America in Congress assembled, 

3 SECTION 1. SHORT TITLE. 

4 This Act may be cited as the ‘‘Alzheimer’s Break5 through Act of 2007’’. 

6 SEC. 2. FINDINGS. 

7 Congress makes the following findings: 


ycherry on PROD1PC64 with BILLS
2 

•HR 1560 IH

1 (1) Alzheimer’s disease is a disorder that de2 stroys cells in the brain. The disease is the leading 

3 cause of dementia, a condition that involves gradual 

4 memory loss, decline in the ability to perform rou5 tine tasks, disorientation, difficulty in learning, loss 

6 of language skills, impairment of judgment, and per7 sonality changes. As the disease progresses, people 

8 with Alzheimer’s disease become unable to care for 

9 themselves. The loss of brain cells eventually leads 

10 to the failure of other systems in the body. 

11 (2) An estimated 4,500,000 Americans have 

12 Alzheimer’s disease and 1 in 10 individuals have a 

13 family member with the disease. By 2050, the num14 ber of individuals with the disease could range from 

15 13,000,000 to 16,000,000 unless science finds a way 

16 to prevent or cure the disease. 

17 (3) One in 10 people over the age of 65, and 

18 nearly half of those over the age of 85 have Alz19 heimer’s disease. Younger people also get the dis20 ease. 

21 (4) The Alzheimer’s disease process may begin 

22 in the brain as many as 20 years before the symp23 toms of Alzheimer’s disease appear. An individual 

24 will live an average of 8 years and as many as 20 

25 once the symptoms of Alzheimer’s disease appear. 


ycherry on PROD1PC64 with BILLS
3 

•HR 1560 IH

1 (5) The average lifetime cost of care for an in2 dividual with Alzheimer’s disease is $170,000. 

3 (6) In 2005, Medicare alone spent 

4 $91,000,000,000 for the care of individuals with 

5 Alzheimer’s disease and this amount is projected to 

6 increase to $160,000,000,000 in 2010. 

7 (7) Ninety-five percent of Medicare beneficiaries 

8 with Alzheimer’s disease have one or more other 

9 chronic conditions that are common in the elderly, 

10 coronary heart disease (30 percent), congestive heart 

11 failure (28 percent), diabetes (21 percent), and 

12 chronic obstructive pulmonary disease (17 percent). 

13 (8) Seven in 10 individuals with Alzheimer’s 

14 disease live at home. While almost 75 percent of 

15 home care is provided by family and friends, the av16 erage annual cost of paid care for people with Alz17 heimer’s disease at home is $19,000 per year. Al18 most all families pay this cost out of pocket. 

19 (9) Half of all nursing home residents have Alz20 heimer’s disease or a related disorder. The average 

21 annual cost of Alzheimer’s disease nursing home 

22 care is more than $70,000. Medicaid pays half of 

23 the total nursing home bill and helps 2 out of 3 resi24 dents pay for their care. Medicaid expenditures for 

25 nursing home care for people with Alzheimer’s disVerDate Aug 31 2005 23:21 Mar 20, 2007 Jkt 059200 PO 00000 Frm 00003 Fmt 6652 Sfmt 6201 E:\BILLS\H1560.IH H1560

ycherry on PROD1PC64 with BILLS
4 

•HR 1560 IH

1 ease are estimated to increase from $21,000,000,000 

2 in 2005 to $24,000,000,000 in 2010. 

3 (10) In fiscal year 2007, the Federal Govern4 ment will spend an estimated $642,000,000 on Alz5 heimer’s disease research. If the United States 

6 achieves its research goals (preventing the onset of 

7 Alzheimer’s disease in those at risk and treating and 

8 delaying progression of the disease in those who 

9 have symptoms), annual Medicare savings would be 

10 $51,000,000,000 by 2015 and $88,000,000,000 by 

11 2020. Annual Medicaid savings would be 

12 $10,000,000,000 in 2015 and $17,000,000,000 by 

13 2020 and the projected number of cases of Alz14 heimer’s disease can be reduced by 40 percent by 

15 the middle of the century. 

16 (11) An analysis by the Montefiore Medical 

17 Center and the Albert Einstein College of Medicine 

18 estimated that the annual value of the informal care 

19 system is $306,000,000,000. Family caregiving 

20 comes at enormous physical, emotional, and financial 

21 sacrifice, putting the whole system at risk. 

22 (12) One in 8 Alzheimer’s disease caregivers be23 comes ill or injured as a direct result of caregiving. 

24 One in 3 uses medication for problems related to 

25 caregiving. Older caregivers are 3 times more likely 


ycherry on PROD1PC64 with BILLS
5 

•HR 1560 IH

1 to become clinically depressed than others in their 

2 age group. 

3 (13) Elderly spouses strained by caregiving are 

4 63 percent more likely to die during a given 4-year 

5 period than other spouses their age. 

6 (14) Almost 3 of 4 caregivers are women. One 

7 in 3 has children or grandchildren under the age of 

8 18 living at home. Caregiving leaves them less time 

9 for other family members and they are much more 

10 likely to report family conflicts because of their 

11 caregiving role. 

12 (15) Most Alzheimer’s disease caregivers work 

13 outside the home before beginning their caregiving 

14 careers, but caregiving forces them to miss work, cut 

15 back to part-time, take less demanding jobs, choose 

16 early retirement, or give up work altogether. As a 

17 result, in 2002, Alzheimer’s disease cost American 

18 business an estimated $36,500,000,000 in lost pro19 ductivity, as well as an additional $24,600,000,000 

20 in business contributions to the total cost of care. 


ycherry on PROD1PC64 with BILLS
6 

•HR 1560 IH

1 TITLE I—INCREASING THE FED2 ERAL COMMITMENT TO ALZ3 HEIMER’S RESEARCH 

4 SEC. 101. DOUBLING NIH FUNDING FOR ALZHEIMER’S DIS5 EASE RESEARCH. 

6 For the purpose of conducting and supporting re7 search on Alzheimer’s disease (including related activities 

8 under subpart 5 of part C of title IV of the Public Health 

9 Service Act (42 U.S.C. 285e et seq.)), there are authorized 

10 to be appropriated $1,300,000,000 for fiscal year 2008, 

11 and such sums as may be necessary for each of fiscal years 

12 2009 through 2012. 

13 SEC. 102. PRIORITY TO ALZHEIMER’S DISEASE RESEARCH. 

14 Section 443 of the Public Health Service Act (42 

15 U.S.C. 285e) is amended— 

16 (1) by striking ‘‘The general’’ and inserting 

17 ‘‘(a) IN GENERAL.—The general’’; and 

18 (2) by adding at the end the following: 

19 ‘‘(b) PRIORITIES.—The Director of the Institute 

20 shall, in expending amounts appropriated to carry out this 

21 subpart, give priority to conducting and supporting Alz22 heimer’s disease research.’’. 


ycherry on PROD1PC64 with BILLS
7 

•HR 1560 IH

1 SEC. 103. ALZHEIMER’S DISEASE PREVENTION INITIATIVE. 

2 Section 443 of the Public Health Service Act (42 

3 U.S.C. 285e), as amended by section 102, is further 

4 amended by adding at the end the following: 

5 ‘‘(c) PREVENTION TRIALS.—The Director of the In6 stitute shall increase the emphasis on the need to conduct 

7 Alzheimer’s disease prevention trials within the National 

8 Institutes of Health. 

9 ‘‘(d) NEUROSCIENCE INITIATIVE.—The Director of 

10 the Institute shall ensure that Alzheimer’s disease is main11 tained as a high priority for the existing neuroscience ini12 tiative.’’. 

13 SEC. 104. ALZHEIMER’S DISEASE CLINICAL RESEARCH. 

14 (a) CLINICAL RESEARCH.—Subpart 5 of part C of 

15 title IV of the Public Health Service Act (42 U.S.C. 285e 

16 et seq.) is amended by adding at the end the following: 

17 ‘‘SEC. 445J. ALZHEIMER’S DISEASE CLINICAL RESEARCH. 

18 ‘‘(a) IN GENERAL.—The Director of the Institute, 

19 pursuant to section 444(d), shall conduct and support co20 operative clinical research regarding Alzheimer’s disease. 

21 Such research shall include— 

22 ‘‘(1) investigating therapies, interventions, and 

23 agents to detect, treat, slow the progression of, or 

24 prevent Alzheimer’s disease; 

25 ‘‘(2) enhancing the national infrastructure for 

26 the conduct of clinical trials; 


ycherry on PROD1PC64 with BILLS
8 

•HR 1560 IH

1 ‘‘(3) developing and testing novel approaches to 

2 the design and analysis of such trials; 

3 ‘‘(4) facilitating the enrollment of patients for 

4 such trials, including patients from diverse popu5 lations; 

6 ‘‘(5) developing improved diagnostics and 

7 means of patient assessment for Alzheimer’s disease; 

8 ‘‘(6) the conduct of clinical trials on potential 

9 therapies, including readily available compounds 

10 such as herbal remedies and other alternative treat11 ments; 

12 ‘‘(7) research to develop better methods of early 

13 diagnosis, including the use of current imaging tech14 niques; and 

15 ‘‘(8) other research as determined appropriate 

16 by the Director of the Institute, the Alzheimer’s Dis17 ease Centers and Alzheimer’s Disease Research Cen18 ters established under section 445. 

19 ‘‘(b) EARLY DIAGNOSIS AND DETECTION RE20 SEARCH.— 

21 ‘‘(1) IN GENERAL.—The Director of the Insti22 tute, in consultation with the directors of other rel23 evant institutes and centers of the National Insti24 tutes of Health, shall conduct, or make grants for 

25 the conduct of, research related to the early detecVerDate Aug 31 2005 23:21 Mar 20, 2007 Jkt 059200 PO 00000 Frm 00008 Fmt 6652 Sfmt 6201 E:\BILLS\H1560.IH H1560

ycherry on PROD1PC64 with BILLS
9 

•HR 1560 IH

1 tion, diagnosis, and prevention of Alzheimer’s dis2 ease and of mild cognitive impairment or other po3 tential precursors to Alzheimer’s disease. 

4 ‘‘(2) EVALUATION.—The research described in 

5 paragraph (1) may include the evaluation of diag6 nostic tests and imaging techniques. 

7 ‘‘(3) STUDY.—Not later than 1 year after the 

8 date of enactment of this section, the Director of the 

9 Institute, in cooperation with the heads of other rel10 evant Federal agencies, shall conduct a study, and 

11 submit to Congress a report, to estimate the number 

12 of individuals with early-onset Alzheimer’s disease 

13 (those diagnosed before the age of 65) and related 

14 dementias in the United States, the causes of early15 onset dementia, and the unique problems faced by 

16 such individuals, including problems accessing gov17 ernment services. 

18 ‘‘(c) VASCULAR DISEASE.—The Director of the Insti19 tute, in consultation with the directors of other relevant 

20 institutes and centers of the National Institutes of Health, 

21 shall conduct, or make grants for the conduct of, research 

22 related to the relationship of vascular disease and Alz23 heimer’s disease, including clinical trials to determine 

24 whether drugs developed to prevent cerebrovascular disVerDate Aug 31 2005 23:21 Mar 20, 2007 Jkt 059200 PO 00000 Frm 00009 Fmt 6652 Sfmt 6201 E:\BILLS\H1560.IH H1560

ycherry on PROD1PC64 with BILLS
10 

•HR 1560 IH

1 ease can prevent the onset or progression of Alzheimer’s 

2 disease. 

3 ‘‘(d) TREATMENTS AND PREVENTION.—The Director 

4 of the Institute shall place special emphasis on expediting 

5 the translation of research findings under this section into 

6 effective treatments and prevention strategies for at-risk 

7 individuals. 

8 ‘‘(e) NATIONAL ALZHEIMER’S COORDINATING CEN9 TER.—The Director of the Institute may establish a Na10 tional Alzheimer’s Coordinating Center to facilitate col11 laborative research among the Alzheimer’s Disease Cen12 ters and Alzheimer’s Disease Research Centers established 

13 under section 445.’’. 

14 (b) ALZHEIMER’S DISEASE CENTERS.—Section 

15 445(a)(1) of the Public Health Service Act (42 U.S.C. 

16 285e–2(a)(1)) is amended by inserting ‘‘, and outcome 

17 measures and disease management,’’ after ‘‘treatment 

18 methods’’. 

19 SEC. 105. RESEARCH ON ALZHEIMER’S DISEASE 

20 CAREGIVING. 

21 Section 445C of the Public Health Service Act (42 

22 U.S.C. 285e–5) is amended— 

23 (1) by striking ‘‘SEC. 445C. (a)’’ and inserting 

24 the following: 


ycherry on PROD1PC64 with BILLS
11 

•HR 1560 IH

1 ‘‘SEC. 445C. RESEARCH ON ALZHEIMER’S DISEASE SERV2 ICES AND CAREGIVING. 

3 ‘‘(a) SERVICES RESEARCH.—’’; 

4 (2) by striking subsections (b), (c), and (e); 

5 (3) by inserting after subsection (a) the fol6 lowing: 

7 ‘‘(b) INTERVENTIONS RESEARCH.—The Director 

8 shall, in collaboration with the directors of the other rel9 evant institutes and centers of the National Institutes of 

10 Health, conduct, or make grants for the conduct of, clin11 ical, social, and behavioral research related to interven12 tions designed to help caregivers of patients with Alz13 heimer’s disease and related disorders and improve patient 

14 outcomes.’’; and 

15 (4) in subsection (d) by striking ‘‘(d) the Direc16 tor’’ and inserting ‘‘(c) MODEL CURRICULAAND

17 TECHNIQUES.—The Director’’. 

18 SEC. 106. NATIONAL SUMMIT ON ALZHEIMER’S DISEASE. 

19 (a) IN GENERAL.—Not later than 3 years after the 

20 date of enactment of this Act, and every 3 years there21 after, the Secretary of Health and Human Services (re22 ferred to in this section as the ‘‘Secretary’’) shall convene 

23 a summit of researchers, representatives of academic insti24 tutions, Federal and State policymakers, public health 

25 professionals, and representatives of voluntary health 

26 agencies to provide a detailed overview of current research 


ycherry on PROD1PC64 with BILLS
12 

•HR 1560 IH

1 activities at the National Institutes of Health, as well as 

2 to discuss and solicit input related to potential areas of 

3 collaboration between the National Institutes of Health 

4 and other Federal health agencies, including the Centers 

5 for Disease Control and Prevention, the Administration on 

6 Aging, the Agency for Healthcare Research and Quality, 

7 and the Health Resources and Services Administration, 

8 related to research, prevention, and treatment of Alz9 heimer’s disease. 

10 (b) FOCUS AREAS.—The summit convened under 

11 subsection (a) shall focus on— 

12 (1) a broad range of Alzheimer’s disease re13 search activities relating to biomedical research, pre14 vention research, and caregiving issues; 

15 (2) clinical research for the development and 

16 evaluation of new treatments for the disease; 

17 (3) translational research on evidence-based and 

18 cost-effective best practices in the treatment and 

19 prevention of the disease; 

20 (4) information and education programs for 

21 health care professionals and the public relating to 

22 the disease; 

23 (5) priorities among the programs and activities 

24 of the various Federal agencies regarding such dis25 eases; and 


ycherry on PROD1PC64 with BILLS
13 

•HR 1560 IH

1 (6) challenges and opportunities for scientists, 

2 clinicians, patients, and voluntary organizations re3 lating to the disease. 

4 (c) REPORT.—Not later than 180 days after the date 

5 on which the National Summit on Alzheimer’s Disease is 

6 convened under subsection (a), the Director of National 

7 Institutes of Health shall prepare and submit to the ap8 propriate committees of Congress a report that includes 

9 a summary of the proceedings of the summit and a de10 scription of Alzheimer’s research, education, and other ac11 tivities that are conducted or supported through the na12 tional research institutes. 

13 (d) PUBLIC INFORMATION.—The Secretary shall 

14 make readily available to the public information about the 

15 research, education, and other activities relating to Alz16 heimer’s disease and other related dementias, conducted 

17 or supported by the National Institutes of Health. 


ycherry on PROD1PC64 with BILLS
14 

•HR 1560 IH

1 TITLE II—PUBLIC HEALTH PRO2 MOTION AND PREVENTION 

3 OF ALZHEIMER’S DISEASE 

4 SEC. 201. ENHANCING PUBLIC HEALTH ACTIVITIES RE5 LATED TO COGNITIVE HEALTH, ALZHEIMER’S 

6 DISEASE, AND OTHER DEMENTIA’S. 

7 Part P of title III of the Public Health Service Act 

8 (42 U.S.C. 280g et seq.) is amended by adding at the end 

9 the following: 

10 ‘‘SEC. 399R. ALZHEIMER’S DISEASE PUBLIC EDUCATION 

11 CAMPAIGN. 

12 ‘‘(a) IN GENERAL.—The Secretary, acting through 

13 the Director of the Centers for Disease Control and Pre14 vention, shall directly or through grants, cooperative 

15 agreements, or contracts to eligible entities, conduct, sup16 port, and promote the coordination of research, investiga17 tions, demonstrations, training, and studies relating to the 

18 control, prevention, and surveillance of the risk factors as19 sociated with cognitive health, Alzheimer’s disease, and 

20 other dementias, and seek early recognition and interven21 tion in the course of Alzheimer’s disease and other demen22 tias. 

23 ‘‘(b) CERTAIN ACTIVITIES.—Activities under sub24 section (a) shall include— 


ycherry on PROD1PC64 with BILLS
15 

•HR 1560 IH

1 ‘‘(1) providing support for the dissemination 

2 and implementation of the Roadmap to Maintaining 

3 Cognitive Health to effectively mobilize the public 

4 health community into action; 

5 ‘‘(2) the development of coordinated public edu6 cation programs, services, and demonstrations which 

7 are designed to increase general awareness of cog8 nitive function and promote a brain healthy lifestyle; 

9 ‘‘(3) the development of targeted communica10 tion strategies and tools to educate health profes11 sionals and service providers about the early recogni12 tion, diagnosis, care, and management of Alz13 heimer’s disease and dementia, and to provide con14 sumers with information about interventions, prod15 ucts, and services that promote cognitive health and 

16 assist consumers in maintaining current under17 standing about cognitive health based on the best 

18 science available; and 

19 ‘‘(4) provide support for the collection, publica20 tion, and analysis of data on the prevalence and inci21 dence of cognitive health, Alzheimer’s disease, and 

22 other dementias, and the evaluation of existing pop23 ulation-based surveillance systems (such as the Be24 havioral Risk Factors Surveillance Survey (BRFFS) 

25 and the National Health Interview Survey (NHIS)) 


ycherry on PROD1PC64 with BILLS
16 

•HR 1560 IH

1 to identify limitations that exist in the area of cog2 nitive health, and if necessary, the development of a 

3 surveillance system for cognitive decline, including 

4 Alzheimer’s disease and dementia. 

5 ‘‘(c) GRANTS.—The Secretary may award grants 

6 under this section— 

7 ‘‘(1) to State and local health agencies for the 

8 purpose of— 

9 ‘‘(A) coordinating activities related to cog10 nitive health, Alzheimer’s disease, and other de11 mentias with existing State-based health pro12 grams and community-based organizations; 

13 ‘‘(B) providing Alzheimer’s disease edu14 cation and training opportunities and programs 

15 for health professionals; and 

16 ‘‘(C) developing, testing, evaluating, and 

17 replicating effective Alzheimer’s disease inter18 vention programs to maintain or improve cog19 nitive health; and 

20 ‘‘(2) to nonprofit private health organizations 

21 with expertise in providing care and services to indi22 viduals with Alzheimer’s disease for the purpose 

23 of— 

24 ‘‘(A) disseminating information to the pub25 lic; 


ycherry on PROD1PC64 with BILLS
17 

•HR 1560 IH

1 ‘‘(B) testing model intervention programs 

2 to improve cognitive health; and 

3 ‘‘(C) coordinating existing services with 

4 State-based health programs. 

5 ‘‘(d) AUTHORIZATION OF APPROPRIATIONS.—For the 

6 purpose of carrying out this section, there are authorized 

7 to be appropriated $15,000,000 for fiscal year 2008, and 

8 such sums as may be necessary for each of fiscal years 

9 2009 through 2012.’’. 

10 TITLE III—ASSISTANCE FOR 

11 CAREGIVERS 

12 SEC. 301. ALZHEIMER’S DISEASE CALL CENTER. 

13 Part P of title III of the Public Health Service Act 

14 (42 U.S.C. 280g et seq.), as amended by section 201, is 

15 further amended by adding at the end the following: 

16 ‘‘SEC. 399S. ALZHEIMER’S DISEASE CALL CENTER. 

17 ‘‘(a) IN GENERAL.—The Secretary, acting through 

18 the Administration on Aging, shall award a cooperative 

19 grant to a non-profit or community-based organization to 

20 support the establishment and operation of an Alzheimer’s 

21 Call Center that is accessible 24 hours a day, 7 days a 

22 week, to provide expert advice, care consultation, informa23 tion, and referrals nationwide at the national and local 

24 level regarding Alzheimer’s disease. 


ycherry on PROD1PC64 with BILLS
18 

•HR 1560 IH

1 ‘‘(b) ACTIVITIES.—The Alzheimer’s Call Center es2 tablished under subsection (a) shall— 

3 ‘‘(1) collaborate with the Administration on 

4 Aging in the development, modification, and execu5 tion of the Call Center’s work plan; 

6 ‘‘(2) assist the Administration on Aging in de7 veloping and sustaining collaborations between the 

8 Alzheimer’s Call Center, the Eldercare Locator, the 

9 grantees under the Alzheimer’s Demonstration Pro10 gram, and the Aging Network; 

11 ‘‘(3) provide a 24-hour a day, 7-days a week 

12 toll-free Call Center with trained professional staff 

13 who are available to provide care consultation and 

14 crisis intervention to individuals with Alzheimer’s 

15 disease and other dementias, their family and infor16 mal caregivers, and others as appropriate; 

17 ‘‘(4) be accessible by telephone through a single 

18 1–800 telephone number, website, and e-mail ad19 dress; and 

20 ‘‘(5) evaluate the impact of the Call Center’s 

21 activities and services. 

22 ‘‘(c) MULTILINGUAL CAPACITY.—The Call Center es23 tablished under this section shall have a multilingual ca24 pacity and shall respond to inquiries in at least 140 lanVerDate Aug 31 2005 23:21 Mar 20, 2007 Jkt 059200 PO 00000 Frm 00018 Fmt 6652 Sfmt 6201 E:\BILLS\H1560.IH H1560

ycherry on PROD1PC64 with BILLS
19 

•HR 1560 IH

1 guages through its own bilingual staff and with the use 

2 of a language translation service. 

3 ‘‘(d) RESPONSE TO EMERGENCY AND ONGOING

4 NEEDS.—The Call Center established under this section 

5 shall collaborate with community-based organizations, in6 cluding non-profit agencies and organizations, to ensure 

7 local, on-the-ground capacity to respond to emergency and 

8 on-going needs of Alzheimer’s patients, their families, and 

9 informal caregivers. 

10 ‘‘(e) AUTHORIZATION OF APPROPRIATIONS.—For the 

11 purpose of carrying out this section, there are authorized 

12 to be appropriated $1,000,000 for fiscal year 2008, and 

13 such sums as may be necessary for each of fiscal years 

14 2009 through 2012.’’. 

15 SEC. 302. INNOVATIVE ALZHEIMER’S CARE STATE MATCH16 ING GRANT PROGRAM. 

17 (a) AUTHORIZATION OF APPROPRIATIONS.—Section 

18 398B(e) of the Public Health Service Act (42 U.S.C. 

19 280c–5(e)) is amended— 

20 (1) by striking ‘‘and such’’ and inserting 

21 ‘‘such’’; and 

22 (2) by inserting before the period the following: 

23 ‘‘, $25,000,000 for fiscal year 2008, and such sums 

24 as may be necessary for each of fiscal years 2009 

25 through 2012’’. 


ycherry on PROD1PC64 with BILLS
20 

•HR 1560 IH

1 (b) PROGRAM EXPANSION.—Section 398(a) of the 

2 Public Health Service Act (42 U.S.C. 280c–3(a)) 

3 (1) in paragraph (2), by inserting after ‘‘other 

4 respite care’’ the following: ‘‘and care consultation 

5 including assessment of needs, assistance with plan6 ning and problem solving and providing supportive 

7 listening’’; 

8 (2) in paragraph (3), by striking ‘‘; and’’ and 

9 inserting the following: ‘‘, and individuals in frontier 

10 areas (as defined as areas with 6 or fewer people per 

11 square mile or areas in which it takes people at least 

12 60 minutes or 60 miles to reach a market or service 

13 area);’’; 

14 (3) in paragraph (4), by striking the period at 

15 the end and inserting a semicolon; and 

16 (4) by adding at the end the following: 

17 ‘‘(5) to encourage grantees under this section to 

18 coordinate activities with other State officials admin19 istering efforts to promote long-term care options 

20 that enable older individuals to receive long-term 

21 care in home- and community-based settings, in a 

22 manner responsive to the needs and preferences of 

23 older individuals and their family caregivers; 

24 ‘‘(6) to encourage grantees under this section 

25 to— 


ycherry on PROD1PC64 with BILLS
21 

•HR 1560 IH

1 ‘‘(A) engage in activities that support early 

2 detection and diagnosis of Alzheimer’s disease 

3 and related dementia; 

4 ‘‘(B) provide training to medical personnel 

5 including hospital staff, emergency room per6 sonnel, home health care workers and physician 

7 office staff, rehabilitation services providers, 

8 and caregivers about how Alzheimer’s can affect 

9 behavior and impede communication in medical 

10 and community settings; 

11 ‘‘(C) develop guidelines to provide the med12 ical community with up-to-date information 

13 about the best methods of care for individuals 

14 with Alzheimer’s disease; 

15 ‘‘(D) inform community physicians about 

16 available resources to assist them in detecting 

17 and managing Alzheimer’s; and 

18 ‘‘(E) raise awareness among community 

19 physicians about the availability of community20 based organizations which can assist individuals 

21 with Alzheimer’s and their caregivers; 

22 ‘‘(7) to encourage grantees under this section to 

23 engage in activities that use findings from evidence24 based research on service models and techniques to 


ycherry on PROD1PC64 with BILLS
22 

•HR 1560 IH

1 support individuals with Alzheimer’s disease and 

2 their caregivers; and 

3 ‘‘(8) to encourage grantees under this section to 

4 incorporate best practices for effectively serving indi5 viduals with Alzheimer’s disease in community-based 

6 settings into ongoing State systems change and 

7 long-term care activities.’’. 

Æ 


ycherry on PROD1PC64 with BILLS